|
US20040009958A1
(en)
*
|
1991-01-08 |
2004-01-15 |
Bone Care International, Inc. |
Methods for preparation and use of 1alpha,24(S)-dihydroxyvitamin D2
|
|
US6538037B2
(en)
*
|
1991-01-08 |
2003-03-25 |
Bone Care International, Inc. |
Methods for preparation and use of 1α,24(S)-dihydroxyvitamin D2
|
|
US5763429A
(en)
*
|
1993-09-10 |
1998-06-09 |
Bone Care International, Inc. |
Method of treating prostatic diseases using active vitamin D analogues
|
|
TW382595B
(en)
*
|
1993-10-15 |
2000-02-21 |
Merck & Co Inc |
Pharmaceutical composition for use in arresting and reversing androgenic alopecia
|
|
US5547957A
(en)
*
|
1993-10-15 |
1996-08-20 |
Merck & Co., Inc. |
Method of treating androgenic alopecia with 5-α reductase inhibitors
|
|
US20040043971A1
(en)
*
|
1995-04-03 |
2004-03-04 |
Bone Care International, Inc. |
Method of treating and preventing hyperparathyroidism with active vitamin D analogs
|
|
US6242434B1
(en)
*
|
1997-08-08 |
2001-06-05 |
Bone Care International, Inc. |
24-hydroxyvitamin D, analogs and uses thereof
|
|
US20020183288A1
(en)
*
|
1995-04-03 |
2002-12-05 |
Bone Care International, Inc. |
Method for treating and preventing hyperparathyroidism
|
|
US20020128240A1
(en)
*
|
1996-12-30 |
2002-09-12 |
Bone Care International, Inc. |
Treatment of hyperproliferative diseases using active vitamin D analogues
|
|
US6566353B2
(en)
*
|
1996-12-30 |
2003-05-20 |
Bone Care International, Inc. |
Method of treating malignancy associated hypercalcemia using active vitamin D analogues
|
|
FR2759293B1
(fr)
*
|
1997-02-11 |
1999-04-30 |
Ethypharm Lab Prod Ethiques |
Microgranules contenant du cisplatine, procede de fabrication, preparation pharmaceutique et utilisation en polychimiotherapie ou en association avec une radiotherapie
|
|
US20030129194A1
(en)
*
|
1997-02-13 |
2003-07-10 |
Bone Care International, Inc. |
Targeted therapeutic delivery of vitamin D compounds
|
|
JP2001511811A
(ja)
*
|
1997-02-13 |
2001-08-14 |
ボーン ケア インターナショナル インコーポレイテッド |
ビタミンｄ化合物の標的治療放出
|
|
US6605599B1
(en)
|
1997-07-08 |
2003-08-12 |
Bristol-Myers Squibb Company |
Epothilone derivatives
|
|
US6087350A
(en)
*
|
1997-08-29 |
2000-07-11 |
University Of Pittsburgh Of The Commonwealth System Of Higher Education |
Use of pretreatment chemicals to enhance efficacy of cytotoxic agents
|
|
WO1999011272A1
(en)
*
|
1997-09-02 |
1999-03-11 |
Johns Hopkins University School Of Medicine |
Vitamin d3 analog loaded polymer formulations for cancer and neurodegenerative disorders
|
|
ES2368824T3
(es)
|
1998-03-27 |
2011-11-22 |
Oregon Health & Science University |
Vitamina d y sus análogos en el tratamiento de tumores y otros desórdenes hiperproliferativos.
|
|
US6849616B1
(en)
*
|
1998-03-27 |
2005-02-01 |
Pharmacia Italia S.P.A. |
Methods to potentiate intravenous estramustine phosphate
|
|
US6479474B2
(en)
*
|
1999-07-08 |
2002-11-12 |
Wisconsin Alumni Research Foundation |
Dietary calcium as a supplement to vitamin D compound treatment of multiple sclerosis
|
|
AU7895601A
(en)
*
|
2000-07-18 |
2002-01-30 |
Bone Care Int Inc |
Stabilized 1alpha-hydroxy vitamin d
|
|
WO2002039996A2
(en)
*
|
2000-11-16 |
2002-05-23 |
Pharmacia & Up John Company |
Combined therapy against tumors comprising estramustine phosphate and lhrh agonists or antagonists
|
|
US20040071789A1
(en)
*
|
2002-02-14 |
2004-04-15 |
Baron John A |
Calcium supplementation to reduce prostate cancer risk
|
|
US7129230B2
(en)
*
|
2001-03-12 |
2006-10-31 |
Nestec S.A. |
Method and product for treating cancer in pets
|
|
JP2005515996A
(ja)
*
|
2001-12-03 |
2005-06-02 |
ノバセア インコーポレイティッド |
活性型ビタミンｄ化合物を含む薬学的組成物
|
|
US20080260834A1
(en)
*
|
2002-08-20 |
2008-10-23 |
Martin Burke |
Vitamin d3 analog loaded polymer formulations for cancer and neurodegenerative disorders
|
|
AU2003273318A1
(en)
*
|
2002-09-12 |
2004-04-30 |
University Of Chicago |
Monitoring and diagnosis of gastric emptying and gastroparesis
|
|
US20040053895A1
(en)
*
|
2002-09-18 |
2004-03-18 |
Bone Care International, Inc. |
Multi-use vessels for vitamin D formulations
|
|
US7148211B2
(en)
*
|
2002-09-18 |
2006-12-12 |
Genzyme Corporation |
Formulation for lipophilic agents
|
|
AU2003295773A1
(en)
*
|
2002-11-21 |
2004-06-18 |
Novacea, Inc. |
Treatment of liver disease with active vitamin d compounds
|
|
CA2528359A1
(en)
*
|
2003-06-11 |
2004-12-23 |
Novacea, Inc. |
Treatment of cancer with active vitamin d compounds in combination with radiotherapeutic agents and treatments
|
|
US20060189586A1
(en)
*
|
2003-06-11 |
2006-08-24 |
Cleland Jeffrey L |
Pharmaceutical compositions comprising active vitamin D compounds
|
|
CA2528378A1
(en)
*
|
2003-06-11 |
2004-12-23 |
Novacea, Inc. |
Treatment of immune-mediated disorders with active vitamin d compounds alone or in combination with other therapeutic agents
|
|
WO2005011660A1
(en)
*
|
2003-07-29 |
2005-02-10 |
Abbott Laboratories |
Use of vitamin d to down regulate the renin-angiotensin-aldosterone system
|
|
CA2539452C
(en)
*
|
2003-09-17 |
2013-10-29 |
Guava Technologies, Inc. |
Compositions and methods for analysis of target analytes
|
|
CA2540325A1
(en)
*
|
2003-09-24 |
2005-04-07 |
Bioxell Spa |
Methods for treating bladder dysfunction
|
|
US7332482B2
(en)
*
|
2003-09-24 |
2008-02-19 |
Bioxell S.P.A. |
Method for treating benign prostatic hyperplasia
|
|
WO2005117542A2
(en)
*
|
2004-05-10 |
2005-12-15 |
Novacea, Inc. |
Treatment of pancreatic cancer with active vitamin d compounds in combination with other treatments
|
|
US7094775B2
(en)
|
2004-06-30 |
2006-08-22 |
Bone Care International, Llc |
Method of treating breast cancer using a combination of vitamin D analogues and other agents
|
|
CA2586679A1
(en)
*
|
2004-11-12 |
2006-05-18 |
Bioxell Spa |
Combined use of vitamin d derivatives and anti-proliferative agents for treating bladder cancer
|
|
CA2624897C
(en)
*
|
2005-10-12 |
2017-02-14 |
Proventiv Therapeutics, Llc |
Methods and articles for treating 25-hydroxyvitamin d insufficiency and deficiency
|
|
EP1968383B1
(en)
*
|
2005-12-12 |
2011-05-11 |
Women and Infants Hospital of Rhode Island |
Derivatives of vitamin d and therapeutic use thereof
|
|
ES2593047T3
(es)
|
2006-02-03 |
2016-12-05 |
Opko Renal, Llc |
Tratamiento de la insuficiencia y deficiencia de vitamina D con 25-hidroxivitamina D2 y 25-hidroxivitamina D3
|
|
US20100009949A1
(en)
*
|
2006-03-24 |
2010-01-14 |
Bioxell S.P.A. |
Novel method
|
|
ES2670029T3
(es)
|
2006-06-21 |
2018-05-29 |
Opko Ireland Global Holdings, Ltd. |
Terapia usando agente de repleción de la vitamina D y agente de reemplazo de la hormona de la vitamina D
|
|
US11752158B2
(en)
*
|
2007-04-25 |
2023-09-12 |
Eirgen Pharma Ltd. |
Method of treating vitamin D insufficiency and deficiency
|
|
US8592401B2
(en)
*
|
2007-04-25 |
2013-11-26 |
Proventiv Therapeutics, Llc |
Methods and compounds for vitamin D therapy
|
|
KR20190028822A
(ko)
|
2007-04-25 |
2019-03-19 |
사이토크로마 인코포레이티드 |
비타민 ｄ 화합물과 밀랍성 담체를 포함하는 경구 조절성 방출 조성물
|
|
HUE073014T2
(hu)
|
2007-04-25 |
2025-12-28 |
Opko Renal Llc |
Eljárás a másodlagos hyperparathyreoidismus biztonságos és hatékony kezelésére és megelõzésére krónikus vesebetegség esetén
|
|
US8221803B1
(en)
|
2007-06-25 |
2012-07-17 |
OncoNatural Solutions, Inc. |
Composition for prostate health
|
|
EP2281058B1
(en)
|
2008-04-02 |
2016-06-29 |
Opko Ireland Global Holdings, Ltd. |
Methods, compositions, uses, and kits useful for vitamin d deficiency and related disorders
|
|
EP2201937A1
(en)
*
|
2008-12-23 |
2010-06-30 |
Teva Pharmaceutical Industries Ltd. |
Formulations comprising vitamin D or derivatives thereof
|
|
WO2010099508A1
(en)
|
2009-02-26 |
2010-09-02 |
Theraquest Biosciences, Inc. |
Extended release oral pharmaceutical compositions of 3-hydroxy-n-methylmorphinan and method of use
|
|
WO2011123476A1
(en)
|
2010-03-29 |
2011-10-06 |
Cytochroma Inc. |
Methods and compositions for reducing parathyroid levels
|
|
US10441561B2
(en)
|
2012-07-26 |
2019-10-15 |
The William M. Yanbrough Foundation |
Method for treating benign prostatic hyperplasia (BPH), prostatitis, and prostate cancer
|
|
US8999393B1
(en)
*
|
2013-01-09 |
2015-04-07 |
Edgemont Pharmaceuticals Llc |
Sustained release formulations of lorazepam
|
|
KR101847947B1
(ko)
|
2013-03-15 |
2018-05-28 |
옵코 아이피 홀딩스 Ⅱ 인코포레이티드 |
안정화되고 변형된 비타민 ｄ 방출 제형
|
|
CN103142554B
(zh)
*
|
2013-03-21 |
2014-11-12 |
青岛正大海尔制药有限公司 |
骨化三醇控释胶囊及其制备方法
|
|
CN103142553B
(zh)
*
|
2013-03-21 |
2014-10-01 |
青岛正大海尔制药有限公司 |
一种骨化三醇缓释胶囊及其制备方法
|
|
CN103142537B
(zh)
*
|
2013-03-21 |
2014-11-12 |
青岛正大海尔制药有限公司 |
骨化三醇缓释剂片
|
|
CN103142555B
(zh)
*
|
2013-03-21 |
2014-10-01 |
青岛正大海尔制药有限公司 |
一种阿法骨化醇缓释胶囊及其制备方法
|
|
JP6282939B2
(ja)
*
|
2014-06-05 |
2018-02-21 |
株式会社ファンケル |
耐酸性錠剤
|
|
US10220047B2
(en)
|
2014-08-07 |
2019-03-05 |
Opko Ireland Global Holdings, Ltd. |
Adjunctive therapy with 25-hydroxyvitamin D and articles therefor
|
|
TW201618783A
(zh)
|
2014-08-07 |
2016-06-01 |
艾森塔製藥公司 |
以布魯頓(Bruton)氏酪胺酸激酶(BTK)佔據和BTK再合成速率為基礎之治療癌症、免疫和自體免疫疾病及發炎性疾病之方法
|
|
JP7032322B2
(ja)
|
2016-03-28 |
2022-03-08 |
オプコ アイルランド グローバル ホールディングス リミテッド |
ビタミンｄ治療法
|
|
KR102121400B1
(ko)
*
|
2018-07-31 |
2020-06-17 |
(주)에이치케이바이오텍 |
신령버섯균사체 액체배양 추출물을 포함하는 전립선 비대증의 예방 또는 치료용 조성물
|
|
JP7603000B2
(ja)
|
2018-08-31 |
2024-12-19 |
オプコ アイルランド グローバル ホールディングス リミテッド |
ビタミンｄ小児用剤形、製造方法および使用方法
|
|
IT201900003843A1
(it)
*
|
2019-03-15 |
2020-09-15 |
Lo Li Pharma Srl |
Trattamento di fibromi con vitamina D e un agente come l'epigallocatechina gallato (EGCG)
|
|
CN110917163A
(zh)
*
|
2019-12-11 |
2020-03-27 |
正大制药（青岛）有限公司 |
一种帕立骨化醇固体口服制剂
|
|
CN110917169A
(zh)
*
|
2019-12-11 |
2020-03-27 |
正大制药（青岛）有限公司 |
帕立骨化醇胶囊剂及其制备方法
|